Curative Biotechnology Inc (CUBT) — Cash Flow Reinvestment Rate

Latest as of December 2022: 0.00x

Curative Biotechnology Inc (CUBT) has a Cash Flow Reinvestment Rate of 0.00x as of December 2022, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $135.81K. See CUBT equity to assets ratio to measure how much of total assets are equity-financed.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$0.00
Capex + Investments

Operating Cash Flow

$135.81K
USD

Capital Expenditures

$0.00
USD

Curative Biotechnology Inc Cash Flow Reinvestment Rate (2015–2015)

Historical reinvestment intensity for Curative Biotechnology Inc across 1 annual periods. Also explore Curative Biotechnology Inc balance sheet assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Curative Biotechnology Inc (2015–2015)

Year-by-year capital reinvestment analysis for Curative Biotechnology Inc. For live market cap and broader valuation context, see Curative Biotechnology Inc (CUBT) total market value.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2015 0.00x $0.00 $1.96K $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow